The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase I/II study of AZD6244 in combination with sorafenib in advanced hepatocellular carcinoma.
Su Pin Choo
No relevant relationships to disclose
Quan Sing Ng
No relevant relationships to disclose
Wallace Jian Jun Chen
No relevant relationships to disclose
Chee Kian Tham
No relevant relationships to disclose
Wei-Peng Yong
No relevant relationships to disclose
Ling Zhi Wang
No relevant relationships to disclose
Tong San Koh
No relevant relationships to disclose
Boon C. Goh
No relevant relationships to disclose
Choon Hua Thng
No relevant relationships to disclose
Hung The Huynh
No relevant relationships to disclose
Ying Kiat Zee
No relevant relationships to disclose
Li shan Low
No relevant relationships to disclose
Han Chong Toh
No relevant relationships to disclose